Skip to main content

Table 1 Description of study sites and intervention implementation in four sites evaluating home management of malaria with artemisinin combination therapy

From: Feasibility and acceptability of artemisinin-based combination therapy for the home management of malaria in four African sites

 

Ejisu – Juaben District, Ghana

Ho District, Ghana

Badeku and Ojoku/Ajia Districts, Nigeria

Bugiri and Iganga Districts, Uganda

Population characteristics

35 rural communities

Population c. 38,000

Perennial malaria transmission

49 urban & rural communities

Population c. 42,000

Perennial malaria transmission

40 rural communities

Population 43,000

Perennial, hyperendemic malaria transmission

56 rural communities

Population c. 60,000

Perennial, hyperendemic transmission

Community medicine distributors

54 (51 male) trusted members of community (farmers, teachers, drug sellers), chosen by the community

76 (48 male) trusted members of community (farmers, teachers, drug sellers), chosen by the community

60 (4 male) including drug sellers, health workers and mothers chosen by the communities

118 (62 male) pre-existing cadre of CMDs (chosen by the community)

 

5 days of training

2 days of training

2 days of training

2 days of training

 

Provided with bicycles, boots & $3.50 monthly

Provided with T-shirts, watches, raincoats, torches & US$8 quarterly

Received commission of 20–30 US cents per pack distributed. Provided with T-shirts, transport reimbursement, Festivity gift, and certificates.

Transport refund of USD 1.16 per meeting. T-shirts, baseball caps, certificates

 

Bimonthly supervision by research staff; Monthly supervision by community Health Officers

Monthly supervision by health staff and quarterly meetings

Monthly supervision by research staff

Monthly supervision by health staff

 

CMDs were not obliged to follow up caregivers. However, some of them followed up and some gave drugs under direct observation.

No active follow-up of caregivers by CMDs.

Program ran within existing home management system. CMDs actively followed up treated children to establish treatment outcome

Drugs and dosing schedule

Artesunate+Amodiaquine (ASAQ) once daily for 3 days

2 types of blister pack, for children < 1 year and children 1 year and above

Artemether-lumefantrine (Coartem®) twice daily for 3 days

2 types of blister pack, for children < 3 years and children 3 years and above

 

10 US cents for <1 year

20 US cents for 1 year and above

20 US cents for < 3 years

30 US cents for 3 years and above Charged for first 6 months only, thereafter free

Free